← Back to directory

Jorge Sánchez‐Guerrero

Researcher Next ID · RN-022073

Researcher · Medicine

Mount Sinai Hospital

Toronto, Mexico

Not currently recruitingFunding unknown
Works count
256
Citation count
28,361
H-index
62
i10-index
139

Research interests

Medicine
Systemic Lupus Erythematosus Research
Rheumatoid Arthritis Research and Therapies
Systemic Sclerosis and Related Diseases
Salivary Gland Disorders and Functions
Multiple Sclerosis Research Studies

Publications

  • Primary Antiphospholipid Syndrome

    Frontiers research topics · 2020 · https://doi.org/10.3389/978-2-88966-108-4

  • 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

    Annals of the Rheumatic Diseases · 2019 · https://doi.org/10.1136/annrheumdis-2018-214819

  • 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    Arthritis & Rheumatology · 2019 · https://doi.org/10.1002/art.40930

  • Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium

    Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2016-209952

  • The frequency and outcome of lupus nephritis: results from an international inception cohort study

    Lara D. Veeken · 2015 · https://doi.org/10.1093/rheumatology/kev311

  • Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

    Annals of the Rheumatic Diseases · 2014 · https://doi.org/10.1136/annrheumdis-2013-205171

  • Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

    Arthritis & Rheumatism · 2012 · https://doi.org/10.1002/art.34359

  • Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials

    Annals of the Rheumatic Diseases · 2012 · https://doi.org/10.1136/annrheumdis-2011-200831

  • Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

    Arthritis & Rheumatism · 2012 · https://doi.org/10.1002/art.34473

  • A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

    Arthritis & Rheumatism · 2011 · https://doi.org/10.1002/art.30613

  • International consensus for a definition of disease flare in lupus

    Lupus · 2010 · https://doi.org/10.1177/0961203310388445

  • Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms

    Proceedings of the National Academy of Sciences · 2010 · https://doi.org/10.1073/pnas.1006980107

  • Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study

    Lara D. Veeken · 2009 · https://doi.org/10.1093/rheumatology/kep346

  • Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus

    Annals of the Rheumatic Diseases · 2009 · https://doi.org/10.1136/ard.2008.106351

  • Interleukin‐6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus

    Arthritis & Rheumatism · 2007 · https://doi.org/10.1002/art.22451

  • A Trial of Contraceptive Methods in Women with Systemic Lupus Erythematosus

    New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa050817

  • The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with Systemic Lupus Erythematosus

    Arthritis & Rheumatism · 1997 · https://doi.org/10.1002/art.1780400506

  • The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus

    Arthritis & Rheumatism · 1996 · https://doi.org/10.1002/art.1780390303

  • Postmenopausal Estrogen Therapy and the Risk for Developing Systemic Lupus Erythematosus

    Annals of Internal Medicine · 1995 · https://doi.org/10.7326/0003-4819-122-6-199503150-00005

  • A connective tissue disease screening questionnaire for population studies

    Annals of Epidemiology · 1995 · https://doi.org/10.1016/1047-2797(94)00096-c

  • Silicone Breast Implants and the Risk of Connective-Tissue Diseases and Symptoms

    New England Journal of Medicine · 1995 · https://doi.org/10.1056/nejm199506223322502

  • Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices.

    PubMed · 1992

  • Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies.

    PubMed · 1990

  • Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients

    Medicine · 1989 · https://doi.org/10.1097/00005792-198911000-00003

Current projects

    No projects listed.